Skip to main content

Table 1 Comparison of baseline information of the four groups

From: Cervical and ocular vestibular evoked myogenic potentials in patients with Diabetic Peripheral Neuropathy

Ā 

Control group

NDPN group

SDPN group

DPN group

n (M/F)

42(23/19)

29(19/10)

26(15/11)

34(23/11)

Age (/year)

52.3ā€‰Ā±ā€‰5.6

52.9ā€‰Ā±ā€‰7.6

51.3ā€‰Ā±ā€‰12.8

51.6ā€‰Ā±ā€‰13.1

BMI(kg/m2)

22.5ā€‰Ā±ā€‰2.1

23.5ā€‰Ā±ā€‰2.6

23.6ā€‰Ā±ā€‰2.3

23.1ā€‰Ā±ā€‰3.1

TG(mmol/l)

1.7ā€‰Ā±ā€‰1.1

1.9ā€‰Ā±ā€‰1.3

1.8ā€‰Ā±ā€‰0.8

1.8ā€‰Ā±ā€‰1.5

HDL-C(mmol/l)

1.3ā€‰Ā±ā€‰0.4

1.1ā€‰Ā±ā€‰0.3

1.2ā€‰Ā±ā€‰0.1

1.3ā€‰Ā±ā€‰0.5

LDL-C(mmol/l)

2.9ā€‰Ā±ā€‰1.1

3.0ā€‰Ā±ā€‰1.2

3.2ā€‰Ā±ā€‰1.0

3.4ā€‰Ā±ā€‰1.1

TC(mmol/l)

4.6ā€‰Ā±ā€‰1.4

4.7ā€‰Ā±ā€‰1.2

4.7ā€‰Ā±ā€‰1.0

5.2ā€‰Ā±ā€‰1.4

UA(umol/L)

300.1ā€‰Ā±ā€‰88.2

355.7ā€‰Ā±ā€‰106.5

308.9ā€‰Ā±ā€‰64.4

325.3ā€‰Ā±ā€‰89.7

HbA1c(%)

5.6ā€‰Ā±ā€‰0.4

8.6ā€‰Ā±ā€‰2.1#

8.7ā€‰Ā±ā€‰2.1#

10.9ā€‰Ā±ā€‰2.5#**

FBG(mmol/L)

5.1ā€‰Ā±ā€‰0.5

8.7ā€‰Ā±ā€‰3.2#

8.9ā€‰Ā±ā€‰3.0#

10.9ā€‰Ā±ā€‰4.9#*

Illness duration(/year)

-

4.2ā€‰Ā±ā€‰4.5#

4.5ā€‰Ā±ā€‰5.1#

7.3ā€‰Ā±ā€‰5.5#*

Hypertension (%)

-

14 (48.27)

13 (50.00)

18 (52.94)

CAD (%)

-

3 (10.34)

3 (11.54)

4 (11.76)

CVD (%)

-

2 (6.89)

2 (7.69)

3 (8.82)

  1. Fā€‰=ā€‰Female, Mā€‰=ā€‰Male; BMIā€‰=ā€‰body mass index; TGā€‰=ā€‰Triglyceride; HDL-Cā€‰=ā€‰high-density lipoprotein; LDL-Cā€‰=ā€‰Low density lipoprotein; TCā€‰=ā€‰Cholesterol; UAā€‰=ā€‰Uric acid; HbA1cā€‰=ā€‰glycated hemoglobin; FBGā€‰=ā€‰fasting blood glucose; CADā€‰=ā€‰coronary artery disease; CVDā€‰=ā€‰cerebrovascular disease;
  2. Compared to healthy control and NDPN groups, #pā€‰<ā€‰0.01; Compared to SDPN group, *pā€‰<ā€‰0.05, **pā€‰<ā€‰0.01